Physician profile
Michael S Grad
NPI 1386629012
$37,818.70
in general payments reported to CMS, 2019-2025
61 companies · $5,979 in 2025
The $5,979 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,121 · 2020: $3,855 · 2021: $5,968 · 2022: $5,928 · 2023: $5,498 · 2024: $5,469 · 2025: $5,979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Education: $55.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,890.63 |
| Education | $55.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,164.69 | 2019-2025 | Gallant, Assurity, Jot Dx |
| Amgen INC. | $2,679.26 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $2,249.22 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,794.26 | 2019-2025 | Leqvio |
| Shockwave Medical, INC | $1,456.12 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Pfizer INC. | $1,448.39 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,435.74 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $1,383.04 | 2022-2025 | Carto 3 |
| Amarin Pharma, INC. | $1,343.77 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $1,333.82 | 2019-2024 | |
| Abiomed | $1,312.33 | 2019-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $1,174.04 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $1,149.14 | 2019-2025 | Watchman Flx, General - Vascular Intervention, Watchman Access System |
| Impulse Dynamics (USA) INC. | $1,118.19 | 2021-2025 | Optimizer, Optimizer |
| Novo Nordisk INC | $1,057.81 | 2021-2025 | Ozempic, Wegovy |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,047.65 | 2019-2025 | Farxiga, Brilinta, Andexxa |
| Atricure, INC. | $878.94 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $762.79 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $752.51 | 2020-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $674.26 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $574.68 | 2019-2024 | Evkeeza, Praluent |
| Merck Sharp & Dohme LLC | $478.15 | 2021-2025 | Verquvo, Capvaxive |
| Penumbra, INC. | $431.63 | 2019-2025 | Indigo System |
| Kiniksa Pharmaceuticals, LTD. | $297.02 | 2021-2023 | Arcalyst |
| Irhythm Technologies, INC. | $278.24 | 2021-2024 | Zio Monitor, Zio Xt Patch |
| Medtronic, INC. | $258.47 | 2021-2025 | Ligasure |
| Arbor Pharmaceuticals, INC. | $225.71 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $219.38 | 2023-2025 | Onpattro, Amvuttra |
| Chiesi USA, INC. | $212.02 | 2020-2025 | Kengreal, Juxtapid |
| Medtronic Vascular, INC. | $186.63 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $178.02 | 2019-2021 | |
| Cardiva Medical, INC. | $177.71 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Bolton Medical INC | $155.92 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Inspire Medical Systems, INC. | $154.53 | 2024-2025 | Inspire |
| Heartflow, INC. | $146.12 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $142.91 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $128.03 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $115.89 | 2024 | Arcalyst |
| Lundbeck LLC | $111.10 | 2019-2020 | |
| Angiodynamics, INC. | $97.06 | 2019-2025 | Auryon Laser System 100-120 Vac |
| Bardy Diagnostics, INC. | $89.53 | 2019-2022 | |
| Glaxosmithkline, LLC. | $89.25 | 2025 | Shingrix, Arexvy |
| Teleflex LLC | $87.29 | 2019-2025 | Guardian, Guideliner, Turnpike |
| Scpharmaceuticals INC. | $76.84 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $76.83 | 2023-2024 | Edarbi, Edarbi |
| Tactile Systems Technology INC | $75.40 | 2019-2021 | |
| Baxter Healthcare | $69.60 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Vital Connect, INC | $60.85 | 2023-2024 | Vitalpatch Rtm |
| Itamar Medical INC | $60.67 | 2022 | |
| Cvrx, INC. | $47.72 | 2021 | |
| Ge Healthcare | $45.95 | 2023-2025 | |
| Corcept Therapeutics | $33.37 | 2021 | |
| Myocardial Solutions, INC. | $32.88 | 2022 | |
| G Medical Diagnostic Services, INC. | $32.40 | 2023 | Cardiac Monitoring Suite |
| Edwards Lifesciences Corporation | $30.56 | 2019 | |
| Agepha Pharma Fz LLC | $28.87 | 2024 | Lodoco |
| Medicure Pharma INC. | $25.93 | 2021 | |
| Lantheus Medical Imaging, INC. | $21.94 | 2023 | Definity |
| Allergan, INC. | $18.74 | 2019 | |
| Djo, LLC | $18.37 | 2021 | |
| Althera Pharmaceuticals LLC | $10.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.